Search Results - "DE ROEMER, Niels Van"
-
1
Exploiting the Mutanome for Tumor Vaccination
Published in Cancer research (Chicago, Ill.) (01-03-2012)“…Multiple genetic events and subsequent clonal evolution drive carcinogenesis, making disease elimination with single-targeted drugs difficult. The multiplicity…”
Get full text
Journal Article -
2
Clarifications concerning the commentary "Published analysis of contraceptive effectiveness of Daysy and DaysyView app is fatally flawed"
Published in Reproductive health (17-06-2019)“…Unfortunately, in this older work, only the PI is comparable. Since Daysy is based on the fertility algorithm of Babycomp and Ladycomp from Valley Electronics,…”
Get full text
Journal Article -
3
-
4
RETRACTED ARTICLE: Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app
Published in Reproductive health (02-03-2018)“…Abstract Background Daysy is a fertility monitor that uses the fertility awareness method by tracking and analyzing the individual menstrual cycle. In…”
Get full text
Journal Article -
5
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Published in Nature (London) (30-04-2015)“…The authors show that a large fraction of tumour mutations is immunogenic and predominantly recognized by CD4 + T cells; they use these data to design…”
Get full text
Journal Article -
6
The performance of a fertility tracking device
Published in The European journal of contraception & reproductive health care (01-04-2021)“…Fertility tracking devices offer women direct-to-user information about their fertility. The objective of this study is to understand how a fertility tracking…”
Get full text
Journal Article -
7
The global pandemic and changes in women's reproductive health: an observational study
Published in The European journal of contraception & reproductive health care (01-04-2022)“…The COVID-19 global pandemic has led to the death of millions around the world and impacted the overall health of many people. In this article we aim to…”
Get full text
Journal Article -
8
Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app
Published in Reproductive health (02-03-2018)“…Daysy is a fertility monitor that uses the fertility awareness method by tracking and analyzing the individual menstrual cycle. In addition, Daysy can be…”
Get full text
Journal Article -
9
Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Published in Nature (London) (16-07-2015)“…Nature 520, 692–696 (2015); doi:10.1038/nature14426 In this Letter, there were minor formatting errors in the poly‐neo‐epitope RNA in Fig. 3a, which occurred…”
Get full text
Journal Article -
10
CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy
Published in Human vaccines & immunotherapeutics (01-01-2016)Get full text
Journal Article Conference Proceeding -
11
CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany
Published in Human vaccines & immunotherapeutics (01-09-2013)“…The 11th Annual Meeting of Association for Cancer Immunotherapy (CIMT) welcomed more than 700 scientists around the world to Mainz, Germany and continued to be…”
Get full text
Journal Article Conference Proceeding -
12
CIMT 2014: Next waves in cancer immunotherapy - Report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6-8 2014, Mainz, Germany
Published in Human vaccines & immunotherapeutics (03-10-2014)Get full text
Journal Article Conference Proceeding -
13
CIMT 2013: Advancing targeted therapies-report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany
Published in Human Vaccines & Immunotherapeutics (19-09-2013)“…The 11th Annual Meeting of Association for Cancer Immunotherapy (CIMT) welcomed more than 700 scientists around the world to Mainz, Germany and continued to be…”
Get full text
Report